Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cone Bioproducts is a specialized manufacturer of human-based biological materials tailored for the in vitro diagnostic (IVD) industry. The company focuses on processing high-quality human serum, plasma, and other biological matrices used as raw materials for diagnostic controls, calibrators, and proficiency testing. Their core competencies include advanced processing techniques such as lipid removal, charcoal stripping, and protein depletion to create customized matrices for clinical laboratory applications. Based in Seguin, Texas, the company provides critical components that support the accuracy of diagnostic assays across clinical chemistry and immunology. Since its acquisition, it operates as part of the LGC Clinical Diagnostics portfolio, continuing to serve global diagnostic manufacturers. The company maintains rigorous quality standards, including ISO 13485 certification, to meet the needs of the global healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cone Bioproducts.